A novel 11C-labeled thymidine analog, [11C]AZT, for tumor imaging by positron emission tomography
Tóm tắt
Nucleoside analogs labeled with positrons, such as 11C and 18F, are considered valuable in visualizing the proliferative activity of tumor cells in vivo using positron emission tomography (PET). We recently developed the 11C-labeled thymidine analogs [11C]zidovudine ([11C]AZT) and [11C]stavudine ([11C]d4T) via the Pd(0)-Cu(I) co-mediated rapid C–C coupling reaction. In this study, to examine whether [11C]AZT and [11C]d4T might be useful for visualization of tumors in vivo, we performed PET imaging, tissue distribution studies, and metabolite analysis in tumor-bearing mice. Mice bearing tumors (rat glioma C6 and human cervical adenocarcinoma HeLa cells) were injected with 50 MBq of [11C]AZT or [11C]d4T, and PET was performed immediately thereafter. After PET imaging, the radioactivity in several tissues, including tumor tissues, was measured using a γ-counter. In addition, radioactive metabolites in plasma, bile, intestinal contents, and tumor were analyzed using thin layer chromatography (TLC). Cellular uptake of [11C]AZT in C6 was measured in the presence or absence of non-labeled thymidine (0.1 mM). In PET studies, C6 and HeLa tumors in mice were clearly visualized using [11C]AZT. Time-activity curves using [11C]AZT showed that the accumulation of radioactivity in tumors plateaued at 10 min after injection and persisted for 60 min, while most of the radioactivity in other tissues was rapidly excreted into the urine. In various tissues of the body, tumor tissue showed the highest radioactivity at 80 min after injection (five to six times higher uptake than that of blood). Compared with tumor tissue, uptake was lower in other proliferative tissues such as the spleen, intestine, and bone marrow, resulting in a high tumor-to-bone marrow ratio. Cellular uptake of [11C]AZT in C6 cells was completely blocked by the application of thymidine, strongly indicating the specific involvement of nucleoside transporters. In contrast, the time-activity curve of [11C]d4T in the tumor showed transient and rapid excretion with almost no obvious tumor tissue accumulation. Tumors can be detected by PET using [11C]AZT; therefore, [11C]AZT could be useful as a novel PET tracer for tumor imaging in vivo.
Tài liệu tham khảo
Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A. 1985;82:7096–100.
Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, et al. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A. 1986;83:8333–7.
Wagner CR, Ballato G, Akanni AO, McIntee EJ, Larson RS, Chang S, et al. Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors. Cancer Res. 1997;57:2341–5.
Lynx MD, Kang BK, McKee EE. Effect of AZT on thymidine phosphorylation in cultured H9c2, U-937, and Raji cell lines. Biochem Pharmacol. 2008;78:1610–5.
Toyohara J, Okada M, Toramatsu C, Suzuki K, Irie T. Feasibility studies of 4'-[methyl-11C]thiothymidine as a tumor proliferation imaging agent in mice. Nucl Med Biol. 2008;35:67–74.
Seitz U, Wagner M, Vogg AT, Glatting G, Neumaier B, Greten FR, et al. In vivo evaluation of 5-[18F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model. Cancer Res. 2001;61:3853–7.
Smith G, Sala R, Carroll L, Behan K, Glaser M, Robins E, et al. Synthesis and evaluation of nucleoside radiotracers for imaging proliferation. Nucl Med Biol. 2012;39:652–65.
Vander Borght T, Labar D, Pauwels S, Lambotte L. Production of [2-11C]thymidine for quantification of cellular proliferation with PET. Int J Rad Appl Instrum A. 1992;42:103–4.
Conti PS, Alauddin MM, Fissekis JR, Schmall B, Watanabe KA. Synthesis of 2'-fluoro-5-[11C]-methyl-1-β-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. Nucl Med Biol. 1995;22:783–9.
Grierson JR, Shields AF. Radiosynthesis of 3'-deoxy-3'-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol. 2000;27:143–56.
Alauddin MM, Conti PS, Fissekis JR. Synthesis of [18F]-labeled 2′-deoxy-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU). J Label Compd Radiopharm. 2002;45:583–90.
Minamimoto R, Toyohara J, Seike A, Ito H, Endo H, Morooka M, et al. 4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer. J Nucl Med. 2011;53:199–206.
Toyohara J, Nariai T, Sakata M, Oda K, Ishii K, Kawabe T, et al. Whole-body distribution and brain tumor imaging with 11C-4DST: a pilot study. J Nucl Med. 2011;52:1322–8.
Zhang Z, Doi H, Koyama H, Watanabe Y, Suzuki M. Efficient syntheses of [11C]zidovudine and its analogues by convenient one-pot palladium(0)-copper(I) co-mediated rapid C-[11C]methylation. J Label Compd Radiopharm. 2014;57:540–9.
Guide for the care and use of laboratory animals 8th ed. Washington, DC: Government Printing Office; 2011. NIH publication 11–103
Tanaka K, Shirotsuki S, Iwata T, Kageyama C, Tahara T, Nozaki S, et al. Template-assisted and self-activating clicked peptide as a synthetic mimic of the SH2 domain. ACS Chem Biol. 2012;7:637–45.
Witney TH, Pisaneschi F, Alam IS, Trousil S, Kaliszezak M, Twyman F, et al. Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection. J Nucl Med. 2014;55:1506–12.
Kawasaki T, Marumo T, Shirakami K, Mori T, Doi H, Suzuki M, et al. Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitor. J Cereb Blood Flow Metab. 2012;32:1737–46.
Tahara T, Tanaka M, Nozaki S, Jin G, Onoe H, Watanabe Y. Decrease of hepatic δ-aminolevulinate dehydratase activity in an animal model of fatigue. Biochem Biophys Res Commun. 2007;353:1068–73.
Nicolas F, De Sousa G, Thomas P, Placidi M, Lorenzon G, Rahmani R. Comparative metabolism of 3'-azido-3'-deoxythymidine in cultured hepatocytes from rats, dogs, monkeys, and humans. Drug Metab Dispos. 1995;23:308–13.
Resetar A, Spector T. Glucuronidation of 3'-azido-3'-deoxythymidine: human and rat enzyme specificity. Biochem Pharmacol. 1989;38:1389–93.
Good SS, Koble CS, Crouch R, Johnson RL, Rideout JL, de Miranda P. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans. Drug Metab Dispos. 1990;18:321–6.
Lynx MD, Kang BK, McKee EE. Effect of AZT on thymidine phosphorylation in cultured H9c2, U-937, and Raji cell lines. Biochem Pharmacol. 2008;75:1610–5.
Lynx MD, Bentley AT, McKee EE. 3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity. Biochem Pharmacol. 2006;71:1342–8.
Chow HH, Li P, Brookshier G, Tang Y. In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice. Drug Metab Dispos. 1997;25:412–22.
Yao SY, Cass CE, Young JD. Transport of the antiviral nucleoside analogues 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes. Mol Pharmacol. 1996;50:388–93.
Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, et al. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Mol Membr Biol. 2001;18:65–72.
Yao SY, Ng AM, Sundaram M, Cass CE, Baldwin SA, Young JD. Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol. 2001;18:161–7.
Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, et al. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogues. J Pharmacol Exp Ther. 2000;294:844–9.
Morita N, Kusuhara H, Sekine T, Endou H, Sugiyama Y. Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. J Pharmacol Exp Ther. 2001;298:1179–84.
Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002;300:918–24.
Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther. 2003;305:1087–97.
Chen R, Nelson JA. Role of organic cation transporters in the renal secretion of nucleosides. Biochem Pharmacol. 2000;60:215–9.
Georgi A, Mottola-Hartshorn C, Warner A, Fields B, Chen LB. Detection of individual fluorescently labeled reovirions in living cells. Proc Natl Acad Sci U S A. 1990;87:6579–83.
Elliott G, O'Hare P. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J Virol. 1999;73:4110–9.